These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 26896692)
21. Impact of viral amino acid substitutions and host interleukin-28b polymorphism on replication and susceptibility to interferon of hepatitis C virus. Hiraga N; Abe H; Imamura M; Tsuge M; Takahashi S; Hayes CN; Ochi H; Tateno C; Yoshizato K; Nakamura Y; Kamatani N; Chayama K Hepatology; 2011 Sep; 54(3):764-71. PubMed ID: 21618576 [TBL] [Abstract][Full Text] [Related]
22. Confounding by Single Nucleotide Polymorphism rs117648444 (P70S) Affects the Association of Interferon Lambda Locus Variants with Response to Interferon-α-Ribavirin Therapy in Patients with Chronic Genotype 3 Hepatitis C Virus Infection. Bhushan A; Ghosh S; Bhattacharjee S; Chinnaswamy S J Interferon Cytokine Res; 2017 Aug; 37(8):369-382. PubMed ID: 28727946 [TBL] [Abstract][Full Text] [Related]
23. Influence of IFNL3.rs12979860 and IFNL4.ss469415590 polymorphism on clearance of hepatitis C virus infection among Egyptians. Knapp S; Zakaria Z; Hashem M; Zaghla H; Khakoo SI; Waked I; Thursz M; Abdelwahab SF Hepatol Int; 2015 Apr; 9(2):251-7. PubMed ID: 25788203 [TBL] [Abstract][Full Text] [Related]
25. Kinetic differences in the induction of interferon stimulated genes by interferon-α and interleukin 28B are altered by infection with hepatitis C virus. Jilg N; Lin W; Hong J; Schaefer EA; Wolski D; Meixong J; Goto K; Brisac C; Chusri P; Fusco DN; Chevaliez S; Luther J; Kumthip K; Urban TJ; Peng LF; Lauer GM; Chung RT Hepatology; 2014 Apr; 59(4):1250-61. PubMed ID: 23913866 [TBL] [Abstract][Full Text] [Related]
26. Distribution of IL28B rs12979860 and rs8099917 Genotypes in Patients with Chronic Hepatitis C Virus Infection in Tianjin, China. Qiao K; Trieu C; Huo Z; Du Y; Hou W Clin Lab; 2018 Apr; 64(4):543-550. PubMed ID: 29739095 [TBL] [Abstract][Full Text] [Related]
27. Prevalence of hepatitis C virus genotype 1a in Japan and correlation of mutations in the NS5A region and single-nucleotide polymorphism of interleukin-28B with the response to combination therapy with pegylated-interferon-alpha 2b and ribavirin. Hayashi K; Katano Y; Kuzuya T; Tachi Y; Honda T; Ishigami M; Itoh A; Hirooka Y; Ishikawa T; Nakano I; Urano F; Yoshioka K; Toyoda H; Kumada T; Goto H J Med Virol; 2012 Mar; 84(3):438-44. PubMed ID: 22246829 [TBL] [Abstract][Full Text] [Related]
28. Role of IL28B for chronic hepatitis C treatment toward personalized medicine. Matsuura K; Watanabe T; Tanaka Y J Gastroenterol Hepatol; 2014 Feb; 29(2):241-9. PubMed ID: 24325405 [TBL] [Abstract][Full Text] [Related]
29. IL28B polymorphism genotyping as predictor of rapid virologic response during interferon plus ribavirin treatment in hepatitis C virus genotype 1 patients. Rosso C; Abate ML; Ciancio A; Strona S; Caviglia GP; Olivero A; Touscoz GA; Rizzetto M; Pellicano R; Smedile A World J Gastroenterol; 2014 Sep; 20(36):13146-52. PubMed ID: 25278709 [TBL] [Abstract][Full Text] [Related]
30. Role of interleukin 28B-related gene polymorphisms in chronic hepatitis C and the response to antiviral therapy in Koreans. Jung YK; Kim JH; Ahn SM; Yang JW; Park SJ; Kim JW; Yeon JE; Kwon OS; Kim YS; Choi DJ; Kim JH; Byun KS J Clin Gastroenterol; 2013 Aug; 47(7):644-50. PubMed ID: 23442843 [TBL] [Abstract][Full Text] [Related]
31. Distinct and overlapping genomic profiles and antiviral effects of Interferon-λ and -α on HCV-infected and noninfected hepatoma cells. Kohli A; Zhang X; Yang J; Russell RS; Donnelly RP; Sheikh F; Sherman A; Young H; Imamichi T; Lempicki RA; Masur H; Kottilil S J Viral Hepat; 2012 Dec; 19(12):843-53. PubMed ID: 23121362 [TBL] [Abstract][Full Text] [Related]
32. Lead-in treatment with interferon-β/ribavirin may modify the early hepatitis C virus dynamics in pegylated interferon alpha-2b/ribavirin combination for chronic hepatitis C patients with the IL28B minor genotype. Itokawa N; Atsukawa M; Tsubota A; Kondo C; Hashimoto S; Fukuda T; Matsushita Y; Kidokoro H; Kobayashi T; Narahara Y; Nakatsuka K; Kanazawa H; Iwakiri K; Sakamoto C J Gastroenterol Hepatol; 2013 Mar; 28(3):443-9. PubMed ID: 23173698 [TBL] [Abstract][Full Text] [Related]
33. Association between CXCL10 and DPP4 Gene Polymorphisms and a Complementary Role for Unfavorable IL28B Genotype in Prediction of Treatment Response in Thai Patients with Chronic Hepatitis C Virus Infection. Thanapirom K; Suksawatamnuay S; Sukeepaisarnjaroen W; Tangkijvanich P; Treeprasertsuk S; Thaimai P; Wasitthankasem R; Poovorawan Y; Komolmit P PLoS One; 2015; 10(9):e0137365. PubMed ID: 26339796 [TBL] [Abstract][Full Text] [Related]
34. IL28B polymorphisms of both recipient and donor cooperate to influence IFN treatment response in HCV recurrence after liver transplantation, but IL28B SNPs of the recipient play a major role in IFN-induced blocking of HCV replication. Barbera F; Russelli G; Pipitone L; Pietrosi G; Corsale S; Vizzini G; Gridelli B; Conaldi PG New Microbiol; 2015 Apr; 38(2):201-10. PubMed ID: 25938745 [TBL] [Abstract][Full Text] [Related]
35. Absence of interferon-λ 4 enhances spontaneous clearance of acute hepatitis C virus genotypes 1-3 infection. Waldenström J; Kåberg M; Alanko Blomé M; Widell A; Björkman P; Nilsson S; Hammarberg A; Weiland O; Nyström K; Lagging M Scand J Gastroenterol; 2021 Jul; 56(7):855-861. PubMed ID: 34034600 [TBL] [Abstract][Full Text] [Related]
36. Interferon-λ4 (IFNL4) transcript expression in human liver tissue samples. Amanzada A; Kopp W; Spengler U; Ramadori G; Mihm S PLoS One; 2013; 8(12):e84026. PubMed ID: 24376784 [TBL] [Abstract][Full Text] [Related]
37. Impact of IL28B gene polymorphisms on interferon-λ3 plasma levels during pegylated interferon-α/ribavirin therapy for chronic hepatitis C in patients coinfected with HIV. Rallón NI; Soriano V; Naggie S; Restrepo C; McHutchison J; Vispo E; Benito JM J Antimicrob Chemother; 2012 May; 67(5):1246-9. PubMed ID: 22294646 [TBL] [Abstract][Full Text] [Related]
39. HCV substitutions and IL28B polymorphisms on outcome of peg-interferon plus ribavirin combination therapy. Hayes CN; Kobayashi M; Akuta N; Suzuki F; Kumada H; Abe H; Miki D; Imamura M; Ochi H; Kamatani N; Nakamura Y; Chayama K Gut; 2011 Feb; 60(2):261-7. PubMed ID: 21068134 [TBL] [Abstract][Full Text] [Related]
40. [IL28B CC genotype: a protective factor and predictor of the response to interferon treatment in chronic hepatitis C virus infection]. Pár A; Pár G; Tornai I; Szalay F; Várszegi D; Fráter E; Papp M; Lengyel G; Fehér J; Varga M; Gervain J; Schuller J; Nemes Z; Péterfi Z; Tusnádi A; Hunyady B; Haragh A; Szinku Z; Pálinkás L; Berki T; Vincze A; Kisfali P; Melegh B Orv Hetil; 2013 Aug; 154(32):1261-8. PubMed ID: 23916907 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]